Step 2/3

Drug-Coated Balloons

Drug-coated balloons (DCB), also referred to as drug-eluting balloons, are used to treat peripheral and coronary artery lesions and restenosis. The balloons carry an antiproliferative drug that is delivered to the wall of arteries when the balloon is expanded. The drug helps prevent neointimal hyperplasia caused by vessel trauma from the balloon angioplasty. Find news and video content on DCBs

Last updated on December 03, 2021
Company Product
BD Lutonix 035
BD Lutonix 035
BD Lutonix 018
Medtronic IN.PactAdmiral Drug-Coated Balloon
Medtronic IN.Pact AV Drug-Coated Balloon
Medtronic IN.Pact Pacific Drug-eluting Balloon
Philips Stellarex 0.035" OTW drug-coated angioplasty balloon

Related Content

News | Drug-Eluting Balloons

November 10, 2021 — Biosensors International Group Ltd., a developer and manufacturer of innovative medical devices ...

Home November 10, 2021
Home
News | Drug-Eluting Balloons

October 20, 2021 — 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a late-breaking ...

Home October 20, 2021
Home
News | Drug-Eluting Balloons

March 12, 2021 — Philips Healthcare announced the final, five-year results of two major randomized controlled trials ...

Home March 12, 2021
Home
News | Drug-Eluting Balloons

November 3, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the Boston Scientific Ranger Drug-coated ...

Home November 03, 2020
Home
News | Drug-Eluting Balloons

October 18, 2020 – The first results from the IN.PACT Below the Knee (BTK) Study, a feasibility study assessing the ...

Home October 18, 2020
Home
Videos | Drug-Eluting Balloons

Juan F. Granada, M.D., CEO of the Cardiovascular Research Foundation (CRF) worked on preclinical development work for a ...

Home September 09, 2020
Home
Feature | Drug-Eluting Balloons | Dave Fornell, Editor

Drug-coated balloons (DCB), also referred to as drug-eluting balloons (DEB), were created as a way to reduce very high ...

Home August 06, 2020
Home
News | Drug-Eluting Balloons

July 7, 2020 – MedAlliance announced enrollment of the first patient in its study of Selution SLR 0.014 drug-eluting ...

Home July 07, 2020
Home
News | Drug-Eluting Balloons

June 19, 2020 — iVascular SLU announced the global launch of Essential Pro, a novel coronary artery drug-coated balloon ...

Home June 19, 2020
Home
News | Drug-Eluting Balloons

June 17, 2020 — MedAlliance announced its second CE mark approval for its Selution SLR 0.014 percutaneous transluminal ...

Home June 18, 2020
Home
Subscribe Now